Jim Wassil - Oct 28, 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF OPERATING OFFICER
Signature
Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol
PCVX
Transactions as of
Oct 28, 2024
Transactions value $
$80,981
Form type
4
Date filed
10/29/2024, 07:41 PM
Previous filing
Oct 3, 2024
Next filing
Nov 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $8.48K +1.59K +0.79% $5.35 202K Oct 28, 2024 Direct F1
transaction PCVX Common Stock Options Exercise $72.5K +3.46K +1.71% $20.93 206K Oct 28, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -1.59K -2.02% $0.00 77K Oct 28, 2024 Common Stock 1.59K $5.35 Direct F2
transaction PCVX Stock Option (right to buy) Options Exercise $0 -3.46K -3.71% $0.00 89.9K Oct 28, 2024 Common Stock 3.46K $20.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024.
F2 Stock Option is fully vested and exercisable.
F3 1/48 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.